The Effect of Aromatherapy on Cognitive Functions, Anxiety and Sleep
NCT ID: NCT04948931
Last Updated: 2022-03-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
63 participants
INTERVENTIONAL
2021-07-28
2022-03-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Aromatherapy on Venopuncture Pain and Anxiety
NCT02592044
The Effect of Lavender Inhalation on Sleep Quality in Individuals With Coronary Heart Disease
NCT05704946
Aromatherapy Applied to Intensive Care Nurses Effect on Fatigue and Sleep Quality
NCT06474793
The Effect of Aromatherapy Applied to the Patients in the Urodynamic Procedure
NCT05255874
Effect of Aromatherapy on Pain, Anxiety and Sleep Quality in Burn Patients
NCT05728190
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lavender aromatherapy
As an intervention to this group, lavender application will be made by inhalation. Participants will apply lavender oil in half an hour before going to bed every night for a month under the supervision of a relative. The application will be done by dripping three drops on cotton, holding it 5-10 cm away from the nose for five minutes and breathing normally.
Lavender aromatherapy
The application will be once a day, every day for four weeks. Each session will take five minutes.
Rosemary aromatherapy
As an intervention to this group, rosemary application will be made by inhalation. Participants will apply rosemary oil in half an hour before going to bed every night for a month under the supervision of a relative. The application will be done by dripping three drops on cotton, holding it 5-10 cm away from the nose for five minutes and breathing normally.
Rosemary aromatherapy
The application will be once a day, every day for four weeks. Each session will take five minutes.
Control
Distilled water will be used for the application to this group. The application will be made every night for a month, half an hour before going to bed, under the supervision of a relative. Participants will apply distilled water by dropping three drops on cotton, holding it 5-10 cm away from the nose, for five minutes and breathing normally.
Control
The application will be once a day, every day for four weeks. Each session will take five minutes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lavender aromatherapy
The application will be once a day, every day for four weeks. Each session will take five minutes.
Rosemary aromatherapy
The application will be once a day, every day for four weeks. Each session will take five minutes.
Control
The application will be once a day, every day for four weeks. Each session will take five minutes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Those aged 65 and over
* Diagnosed with diabetes for at least 1 year
* Having no problems with hearing, speaking, seeing and smelling in a way that hinders communication
* Those who have no problem in verbal communication
* Passing the sense of smell test
* Not taking current anxiolytic or hypnotic therapy
* Not diagnosed with a psychiatric illness and without a diagnosis of mental disability
* Do not have any respiratory system disease such as asthma, COPD and allergic skin disease
* No diagnosis of epilepsy disease
* No known allergy to essential oils to be used in the application
* Those who did not use any of the other complementary and integrative application methods at the time of the study.
* Not using sleeping pills
Exclusion Criteria
* Not attending one of the sessions
* Unwillingness to cooperate with the study
* In addition to existing diseases, respiratory system diseases such as asthma, COPD and allergic diseases
* Known allergy to essential oils and oil used in the study.
* Failed to pass the sense of smell test.
* Receiving anxiolytic or hypnotic therapy
* Those with a diagnosis of psychiatric illness
* Those with a diagnosis of epilepsy disease
* Speech, hearing and vision loss
* Those who do not agree to participate in the research
* Living alone
65 Years
99 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abant Izzet Baysal University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Satı Can
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yasemin YILDIRIM USTA, Prof
Role: STUDY_DIRECTOR
Bolu Abant Izzet Baysal University, Health Sciences Faculty, Department of Nursing
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SATI CAN
Bolu, Center, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AIBU-SBF-SC-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.